Guardant Health Inc (NASDAQ:GH) shares, rose in value on Thursday, March 27, with the stock price down by -1.51% to the previous day’s close as strong demand from buyers drove the stock to $45.15.
Actively observing the price movement in the last trading, the stock closed the session at $45.84, falling within a range of $44.285 and $46.88. The value of beta (5-year monthly) was 1.503. Referring to stock’s 52-week performance, its high was $50.89, and the low was $15.81. On the whole, GH has fluctuated by 4.54% over the past month.
With the market capitalization of Guardant Health Inc currently standing at about $5.57 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-19.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 855.86M, with a low estimate of 186M and a high estimate of 199M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 189.94M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that GH’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of GH currently trading nearly 5.00% and 1.85% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 53.55, while the 7-day volatility ratio is showing 4.98% which for the 30-day chart, stands at 6.88%. Furthermore, Guardant Health Inc (GH)’s beta value is 1.44, and its average true range (ATR) is 2.82.
A comparison of Guardant Health Inc (GH) with its peers suggests the former has fared considerably weaker in the market. GH showed an intraday change of -1.51% in last session, and over the past year, it grew by 161.74%%.
Data on historical trading for Guardant Health Inc (NASDAQ:GH) indicates that the trading volumes over the past 10 days have averaged 1.74 and over the past 3 months, they’ve averaged 2.38 million. According to company’s latest data on outstanding shares, there are 123.99 million shares outstanding.
Nearly 4.42% of Guardant Health Inc’s shares belong to company insiders and institutional investors own 96.26% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.35 million shares as on 2025-03-14, resulting in a short ratio of 3.18. According to the data, the short interest in Guardant Health Inc (GH) stood at 705.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 7.84 million. The stock has risen by 47.79% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GH stock heading into the next quarter.
